Rectal cancer · Adults (general population)
Meta-analysis of observational studies (higher vs lower 25(OH)D) for Rectal cancer: OR 0.50 (95% CI 0.29 to 0.88), statistically significant. Umbrella review outcome-level evidence grade: No conclusion.
1 finding from 1 review
Intervention not reported
At least 50% reduction in pain or equivalent · adults with complex regional pain syndrome type 1 (lower limb)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
At least 30% reduction in pain · adults with complex regional pain syndrome type 1 (lower limb)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Proportion below 30/100 mm on VAS · adults with complex regional pain syndrome type 1 (lower limb)
1 finding from 1 review
no estimate extracted
19 participants
Very low
Intervention not reported
Patient Global Impression of Change: much or very much improved · adults with complex regional pain syndrome type 1 (lower limb)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Adverse event withdrawals · adults with complex regional pain syndrome type 1 (lower limb)
1 finding from 1 review
no estimate extracted
20 participants
Very low
Intervention not reported
Serious adverse events · adults with complex regional pain syndrome type 1 (lower limb)
1 finding from 1 review
no estimate extracted
20 participants
Very low
Intervention not reported
Death · adults with complex regional pain syndrome type 1 (lower limb)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects · Participants with a previous or current history of recurrent aphthous stomatitis (RAS), diagnosed on history and clinical examination;…
1 finding from 1 review
Effectiveness · Participants with a previous or current history of recurrent aphthous stomatitis (RAS), diagnosed on history and clinical examination;…
1 finding from 1 review
Deaths · patients with acute organophosphate pesticide poisoning
It is very uncertain whether higher dose changes deaths compared with lower dose (very low certainty).
1 finding from 1 review
Intermediate syndrome · patients with acute organophosphate pesticide poisoning
It is very uncertain whether higher dose changes intermediate syndrome compared with lower dose (very low certainty).
1 finding from 1 review
Ventilated · patients with acute organophosphate pesticide poisoning
It is very uncertain whether higher dose changes ventilated compared with lower dose (very low certainty).
1 finding from 1 review
Intervention not reported
mg/day LDL cholesterol · participants with normal or abnormal lipid profiles
The intervention showed no clear difference in mg/day LDL cholesterol (high certainty).
1 finding from 1 review
Intervention not reported
mg/day LDL cholesterol · participants with normal or abnormal lipid profiles
The intervention showed no clear difference in mg/day LDL cholesterol (moderate certainty).
1 finding from 1 review
Intervention not reported
mg/day LDL cholesterol · participants with normal or abnormal lipid profiles
The intervention showed no clear difference in mg/day LDL cholesterol (moderate certainty).
1 finding from 1 review
Intervention not reported
mg/day LDL cholesterol · participants with normal or abnormal lipid profiles
The intervention showed no clear difference in mg/day LDL cholesterol (high certainty).
1 finding from 1 review
Intervention not reported
Pravastatin 10 to 80 mg/day (6 to 156 weeks) · participants with normal or abnormal lipid profiles
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
WDAEs · participants with normal or abnormal lipid profiles
It is very uncertain whether the intervention changes WDAEs (very low certainty).
1 finding from 1 review
Underweight · healthy, full‐term (37 to 42 weeks), formula‐fed infants
1 finding from 1 review